Holen Sie sich die Stockscreener-App
81.35
0.43%
-0.35
Handel nachbörslich:
81.35
Finanzdaten der Tarsus Pharmaceuticals Inc-Aktie (TARS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
31.05%
102.66
|
78.33 | 66.41 | 48.12 | 40.81 |
Operating Expenses
|
19.34%
124.84
|
104.61 | 90.83 | 73.28 | 74.11 |
| Benefits Costs and Expenses |
19.34%
124.84
|
104.61 | 85.81 | 73.28 | 74.11 |
| Costs And Expenses |
19.34%
124.84
|
104.61 | 90.83 | 73.28 | 74.11 |
| Operating Income/Loss |
15.59%
-22.18
|
-26.28 | -24.42 | -25.16 | -33.30 |
| Nonoperating Income/Loss |
58.97%
1.844
|
1.16 | 1.308 | 1.742 | 0.012 |
| Income/Loss From Continuing Operations Before Tax |
11.69%
-22.18
|
-25.12 | -19.41 | -25.16 | -33.29 |
| Income/Loss From Continuing Operations After Tax |
19.03%
-20.34
|
-25.12 | -23.11 | -23.42 | -33.29 |
|
Net Income/Loss
|
19.03%
-20.34
|
-25.12 | -23.11 | -23.42 | -33.29 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
7.66%
42.36
|
39.35 | 0.3176 | 38.38 | 37.82 |
| Diluted Average Shares |
7.66%
42.36
|
39.35 | 0.3176 | 38.38 | 37.82 |
| Basic Earnings Per Share |
25.00%
-0.48
|
-0.64 | -0.59 | -0.61 | -0.88 |
| Diluted Earnings Per Share |
25.00%
-0.48
|
-0.64 | -0.59 | -0.61 | -0.88 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):